Clinical Markers

Control Group

PAT Group
Visit 0 (±SE) Visit 1 (±SE) Mean Difference
(Paired t test) 		Visit 0 (±SE) Visit 1 (±SE) Mean Difference
(Paired t test)
Systolic BP (mmHg) 115
±10		 109
±4 		-6
(P >0.1)		 116
±7		 112
±2		 -4
(P >0.05)
Diastolic BP (mmHg) 79
±5		 76
±3		 -3
(P >0.1)		 79
±4		 75
±1		 -4
(P >0.1)
BMI (kg/m2) 26.60
±1.77		 26.35
±1.72		 -0.25
(P <0.05)		 26.60
±1.62		 26.25
±1.81		 -0.35
(P =0.01)
BF (%) 37.60
±1.99		 37.42
±1.92		 -0.20
(P >0.05)		 37.37
±2.59		 36.57
±2.66		 -0.80
(P <0.001)
LMM (kg) 38.4
±2.4 		38.2
±2.3		 -0.2
(P >0.05)		 38.5
±2.9		 38.5
±3.0		 0
(P >0.1)
WC (cm) 93.0
±3.0		 91.0
±3.0		 -2.0
(P <0.05)		 89.0
±7.0		 86.0
±6.5		 -3.0
(P =0.01)
WHR 0.91
±0.02		 0.88
±0.02		 -0.03
(P <0.05)		 0.86
±0.02		 0.83
±0.01 		-0.03
(P =0.01)
Table 1: Clinical markers at baseline (visit 0) and follow-up visit (visit 1) of control group (n =5) versus PAT group (n =10). Mean intervals between visits are 2.8 weeks and 2.9 weeks respectively. Key endpoint differences between control and PAT groups are shaded in black and grey.